Development of S-equol, a Natural, Selective Estrogen Receptor β (ERβ) Agonist for the Treatment of Menopausal Symptoms

被引：0
|
作者：
Schwen, Rick [1 ,2 ]
Greiwe, Jeffrey [2 ]
Desai, Pakaj [1 ]
Jackson, Richard [2 ]
机构：
[1] Univ Cincinnati, Coll Pharm, Cincinnati, OH 45267 USA
[2] Ausio Pharmaceut LLC, Cincinnati, OH USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2010年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1217 / 1218
页数：2
相关论文
共 50 条
  • [21] Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open-label pilot study
    Takeda, Takashi
    Chiba, Yasutaka
    [J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2022, 42 (02) : 127 - 134
  • [22] The Pairing of a Selective Estrogen Receptor Modulator, Bazedoxifene, with Conjugated Estrogens as a New Paradigm for the Treatment of Menopausal Symptoms and Osteoporosis Prevention
    Kharode, Yogendra
    Bodine, Peter V. N.
    Miller, Christopher P.
    Lyttle, C. Richard
    Komm, Barry S.
    [J]. ENDOCRINOLOGY, 2008, 149 (12) : 6084 - 6091
  • [23] Anxiolytic Effects and Neuroanatomical Targets of Estrogen Receptor-β (ERβ)Activation by a Selective ERβ Agonist in Female Mice
    Oyola, Mario G.
    Portillo, Wendy
    Reyna, Andrea
    Foradori, Chad D.
    Kudwa, Andrea
    Hinds, Laura
    Handa, Robert J.
    Mani, Shaila K.
    [J]. ENDOCRINOLOGY, 2012, 153 (02) : 837 - 846
  • [24] Selective human estrogen receptor partial agonist (ShERPAs) for treatment of tamoxifen-resistant ER plus breast cancer
    Delgado-Rivera, Loruhama M.
    [J]. CANCER RESEARCH, 2016, 76
  • [25] S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial floral
    Setchell, KDR
    Clerici, C
    Lephart, ED
    Cole, SJ
    Heenan, C
    Castellani, D
    Wolfe, BE
    Nechemias-Zimmer, L
    Brown, NM
    Lund, TD
    Handa, RJ
    Heubi, JE
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 81 (05): : 1072 - 1079
  • [26] Treatment with estrogen receptor agonist ERβ, but not ERα, improves torsion induced oxidative testis injury in rats
    Tamer, S. Arabaci
    Arabaci, S.
    Ciftci, S.
    Akin, S.
    Sari, E.
    Ahmetoglu, H.
    Koroglu, M. K.
    Ercan, F.
    Yuksel, M.
    Yildirim, A.
    Yegen, B.
    [J]. ACTA PHYSIOLOGICA, 2017, 221 : 258 - 258
  • [27] Erb-041 -: Estrogen receptor (ER) β agonist treatment of endometriosis treatment of rheumatoid arthritis
    Malamas, MS
    Keith, JC
    Harris, HA
    [J]. DRUGS OF THE FUTURE, 2005, 30 (04) : 333 - 336
  • [28] MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms
    Leitman, Dale C.
    Christians, Uwe
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (07) : 1031 - 1042
  • [29] Effect of estrogen receptor agonists treatment in MPTP mice:: evidence of neuroprotection by an ERα agonist
    D'Astous, M
    Morissette, M
    Di Paolo, T
    [J]. NEUROPHARMACOLOGY, 2004, 47 (08) : 1180 - 1188
  • [30] Tissue-Selective Estrogen Complex Bazedoxifene and Conjugated Estrogens for the Treatment of Menopausal Vasomotor Symptoms
    Stovall, Dale W.
    Tanner-Kurtz, Kirby
    Pinkerton, JoAnn V.
    [J]. DRUGS, 2011, 71 (13) : 1649 - 1657
12345